Registry for T-Cell Lymphoma
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to collect and analyze information to better understand T-cell lymphoma, a type of cancer affecting the immune system. Researchers will use the data to find ways to improve treatment outcomes for those with this condition. The trial seeks individuals diagnosed with specific types of T-cell or natural killer (NK) cell lymphoma, particularly those currently receiving systemic therapy (treatment affecting the entire body). As a Phase 2 trial, this research focuses on measuring the treatment's effectiveness in an initial, smaller group, offering participants a chance to contribute to advancements in therapy.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you have mycosis fungoides, primary cutaneous anaplastic large cell lymphoma, or primary cutaneous acral CD8+ T-cell lymphoma, you must be on systemic therapy (treatment that affects the entire body).
Why are researchers excited about this trial?
Researchers are excited about this trial because it aims to gather comprehensive data on people with T-cell lymphoma, which could lead to breakthroughs in understanding the disease. Unlike current treatments such as chemotherapy and targeted therapies that directly attack cancer cells, this registry focuses on collecting detailed information to identify patterns, outcomes, and potential new treatment pathways. By analyzing this collected data, researchers hope to discover insights that could lead to more effective and personalized treatments in the future.
Who Is on the Research Team?
Steven Horwitz, MD
Principal Investigator
Memorial Sloan Kettering Cancer Center
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Data Collection
Participants' clinical characteristics and treatment outcomes are collected and stored in a secure database
Follow-up
Participants are monitored for safety and effectiveness after data collection
What Are the Treatments Tested in This Trial?
Interventions
- Registry for T-cell Lymphoma
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Participants with pathologically-confirmed mature T- or natural killer (NK)-cell lymphoma
Find a Clinic Near You
Who Is Running the Clinical Trial?
Memorial Sloan Kettering Cancer Center
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.